Abstract We describe a series of 5 patients in whom the application of consensus criteria for the diagnosis of chronic lymphocytic leukemia (CLL) led to a revised diagnosis. These patients had been recruited in a wider study describing the occurrence of CLL in Kenya. This case series highlights some of the pitfalls of making a diagnosis of CLL without incorporating all criteria.
Introduction
The laboratory diagnosis of lymphoma has evolved over the years from being based on morphology alone to the inclusion of immunophenotyping and molecular data [1] [2] [3] . Specifically, the diagnosis of chronic lymphocytic leukemia (CLL) according to the World Health Organization (WHO) and the International Workshop on CLL (IWCLL) requires the following [3, 4] :
• Duration: Persistent lymphocytosis ≥3 months;
• Counts: Monoclonal B cell count ≥5 × 10 9 /L when there is lymphocytosis only;
• Morphology: Consistent morphology as defined by the French-American-British (FAB) classification [5] ;
• Immunophenotype: The prototype is co-expression of CD5 and CD23 in monoclonal B cells with dim expression of surface immunoglobulin (sIg) and absent/dim CD79b (or CD22), and the absence of expression of FMC7. The scoring system described by Matutes et al. can help distinguish CLL from other non-Hodgkin lymphomas (NHL) on the basis of immunophenotype [6, 7] .
Small lymphocytic lymphoma (SLL) and CLL are different presentations of the same disease [4] .
Materials and methods
Patients were recruited as part of a wider study describing the occurrence of CLL in Kenya [8] . Morphological evaluation was by FAB criteria. Results of immunophenotyping were interpreted based on the scoring system described by Matutes et al. [6, 7] . was uncertain as records were not accessible. However, history was significant for erythromelalgia and persistent thrombocytosis, and the patient had not received any therapy for CLL. Physical examination was noteworthy for the presence of moderate splenomegaly. Interestingly, the patient did not have lymphocytosis. Subsequent blood counts were also negative for lymphocytosis. There was no evidence of reactive thrombocytosis and bone marrow evaluation done was consistent with essential thrombocythemia (ET).
Criterion: Morphology

Case 2: Case of HCL
A 61-year-old man was seen at AKUH,N seeking a second medical opinion. He had been on follow-up as a case of CLL. Clinical history was remarkable for recurrent anemia, thrombocytopenia, and non-response to chlorambucil therapy. Physical examination was notable for pallor and massive splenomegaly. Morphology was, however, inconsistent with CLL as per the FAB criteria (Fig. 1) . Immunophenotyping confirmed the suspected diagnosis of hairy cell leukemia (HCL). The immunophenotype was CD5−, CD23 borderline, bright sIg expression with lambda restriction, CD11c/ CD22 co-expression with bright CD22 expression, FMC7 positive, and CD103+.
Criterion: Immunophenotype
Case 3-5: Cases of diagnostic uncertainty
Case 3 was a 50-year-old female patient who had initially been diagnosed as CLL on morphological evaluation of a bone marrow aspirate. However, on immunophenotyping of a peripheral blood sample with leukocytosis, most cells were weak CD45 positive and suspicious for blasts. The cells were CD19 positive and lacked surface immunoglobulin expression. Further immunophenotyping confirmed the diagnosis of acute lymphoblastic leukemia (ALL) and an amended report was issued (Fig. 2) .
Cases 4 and 5 were elderly male patients with sustained lymphocytosis. However, morphological evaluation was not conclusive due to the presence of cleaved cells and moderate amounts of cytoplasm (Fig. 3) . A diagnosis of a chronic lymphoproliferative disorder (CLPD) was given and CLL/ SLL and follicular lymphoma were suggested as possibilities. The immunophenotype for both, however, scored 5/5 which is highly specific for CLL [6] . CD 10 was negative for both.
Discussion
The incorporation of relevant criteria for diagnosis of various hematological malignancies is not merely of academic interest. It results in appropriate classification, prognostication, and management of patients. The management principles of ALL, HLL, and ET differ from those of CLL/SLL [4, 9] . Altering the diagnosis for the patients described in this series, therefore, optimized their management.
While sub-Saharan Africa is plagued by resource limitations [10] , incorporation of requisite criteria is vital when circumstances permit an optimal evaluation. However, even in the absence of access to more specialized tests like immunophenotyping, clinical correlation using simple criteria like the presence and persistence of lymphocytosis can go a long way in distinguishing transient from clonal causes of lymphocytosis. Building expertise in microscopy would also go a long way in the recognition of classic features such as those seen in Case 2.
Conclusion
The application of the WHO criteria for the diagnosis of lymphomas including CLL/SLL results in better definition of disease entities. Where resources allow, morphological evaluation should be supported by the relevant diagnostic tests.
